SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-20-027410
Filing Date
2020-12-07
Accepted
2020-12-07 06:45:30
Documents
2
Period of Report
2021-01-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A nc10017450x1_pre14a.htm PRE 14A 237928
2 logo_mackenzie3.jpg GRAPHIC 20552
  Complete submission text file 0001140361-20-027410.txt   267114
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38022 | Film No.: 201371298
SIC: 2834 Pharmaceutical Preparations